Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Ioanna Giannopoulou
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
37
Nakopoulou, Lydia
20
Keramopoulos, Antonios
17
Mylona, Eleni
11
Markaki, Sophia
11
Alexandrou, Paraskevi
7
Lazaris, Andreas
7
Panayotopoulou, Effie
5
Nomikos, Alexandros
5
Tsirmpa, Ioanna
5
Zervas, Anastasios
5
Katsarou, Sophia
5
Mavrommatis, John
5
Magkou, Christina
5
Davaris, Panagiotis
5
Davaris, Panayiotis
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Ioanna Giannopoulou (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Alexandraki Krystallenia I; Michail Othon P; Nonni Afrodite; Diamantis Dimitrios; Giannopoulou Ioanna; Kaltsas Gregory A; Tseleni-Balafouta Sofia; Syriou Vassiliki; Michail Panayiotis O
Corticomedullary mixed adrenal tumor: case report and literature review.
Endocrine journal 2009;56(6):817-24.
-
2009: Mylona E; Giannopoulou I; Diamantopoulou K; Bakarakos P; Nomikos A; Zervas A; Nakopoulou L
Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(2):197-201.
-
2008: Mylona Eleni; Giannopoulou Ioanna; Fasomytakis Emmanouil; Nomikos Alexandros; Magkou Christina; Bakarakos Panagiotis; Nakopoulou Lydia
The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
Human pathology 2008;39(7):1096-102.
-
2008: Mylona E; Zarogiannos A; Nomikos A; Giannopoulou I; Nikolaou I; Zervas A; Nakopoulou L
Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2008;116(1):59-65.
-
2008: Magkou Christina; Nakopoulou Lydia; Zoubouli Christina; Karali Kanelina; Theohari Irene; Bakarakos Panagiotis; Giannopoulou Ioanna
Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas.
Breast cancer research : BCR 2008;10(3):R49.
-
2007: Magkou C; Mylona E; Theohari I; Giannopoulou I; Papanikolaou E; Markaki S; Nakopoulou L
An immunohistochemical evaluation of phosphorylated Akt at threonine 308 [pAkt(Thr308)] in invasive breast cancer.
In vivo (Athens, Greece) 2007;21(6):967-72.
-
2007: Mylona E; Nomikos A; Alexandrou P; Giannopoulou I; Keramopoulos A; Nakopoulou L
Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression.
Histology and histopathology 2007;22(8):825-35.
-
2007: Nakopoulou Lydia; Panayotopoulou Effie G; Giannopoulou Ioanna; Tsirmpa Ioanna; Katsarou Sophia; Mylona Eleni; Alexandrou Paraskevi; Keramopoulos Antonios
Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis.
Journal of clinical pathology 2007;60(7):808-15.
-
2007: Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2007;33(3):294-300.
-
2007: Mylona Eleni; Alexandrou Paraskevi; Giannopoulou Ioanna; Liapis George; Sofia Markaki; Keramopoulos Antonios; Nakopoulou Lydia
The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.
Gynecologic oncology 2007;104(3):557-63.
-
2007: Giannopoulou I; Mylona E; Kapranou A; Mavrommatis J; Markaki S; Zoumbouli Ch; Keramopoulos A; Nakopoulou L
The prognostic value of the topographic distribution of uPAR expression in invasive breast carcinomas.
Cancer letters 2007;246(1-2):262-7.
-
2007: Liapis George; Mylona Eleni; Alexandrou Paraskevi; Giannopoulou Ioanna; Nikolaou Irini; Markaki Sofia; Keramopoulos Antonios; Nakopoulou Lydia
Effect of the different phosphorylated Smad2 protein localizations on the invasive breast carcinoma phenotype.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2007;115(2):104-14.
-
2006: Mylona Eleni; Magkou Christina; Gorantonakis George; Giannopoulou Ioanna; Nomikos Alexandros; Zarogiannos Aristides; Zervas Anastasios; Nakopoulou Lydia
Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder.
Anticancer research 2006;26(5A):3567-71.
-
2006: Nakopoulou Lydia; Mylona Eleni; Papadaki Ioanna; Kavantzas N; Giannopoulou I; Markaki S; Keramopoulos A
Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(4):556-63.
-
2006: Mylona Eleni; Magkou Christina; Giannopoulou Ioanna; Agrogiannis George; Markaki Sofia; Keramopoulos Antonios; Nakopoulou Lydia
Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome.
Breast cancer research : BCR 2006;8(5):R57.
-
2006: Mylona Eleni E; Alexandrou Paraskevi Th; Giannopoulou Ioanna A; Rafailidis Petros I; Markaki Sofia; Keramopoulos Antonios; Nakopoulou Lydia L
Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
Cancer detection and prevention 2006;30(2):111-7.
-
2005: Nakopoulou L; Mylona E; Rafailidis P; Alexandrou P; Giannopoulou I; Keramopoulos A
Effect of different ERK2 protein localizations on prognosis of patients with invasive breast carcinoma.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2005;113(10):693-701.
-
2005: Papadaki I; Mylona E; Giannopoulou I; Markaki S; Keramopoulos A; Nakopoulou L
PPARgamma expression in breast cancer: clinical value and correlation with ERbeta.
Histopathology 2005;46(1):37-42.
-
2005: Nakopoulou L; Mylona E; Papadaki I; Kapranou A; Giannopoulou I; Markaki S; Keramopoulos A
Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma.
Pathobiology : journal of immunopathology, molecular and cellular biology 2005;72(5):241-9.
-
2004: Nakopoulou L; Lazaris A C; Panayotopoulou E G; Giannopoulou I; Givalos N; Markaki S; Keramopoulos A
The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.
Journal of clinical pathology 2004;57(5):523-8.
-
2003: Nakopoulou L; Giannopoulou I; Lazaris A Ch; Alexandrou P; Tsirmpa I; Markaki S; Panayotopoulou E; Keramopoulos A
The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(11):1027-36.
-
2002: Nakopoulou Lydia; Panayotopoulou Effie G; Giannopoulou Ioanna; Alexandrou Paraskevi; Katsarou Sophia; Athanassiadou Pauline; Keramopoulos Antonios
Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(11):1154-61.
-
2002: Giannopoulou Ioanna; Nakopoulou Lydia; Zervas Anastasios; Lazaris Andreas C; Stravodimos Constandinos; Giannopoulos Aris; Davaris Panagiotis S
Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications.
Urological research 2002;30(5):342-5.
-
2002: Nakopoulou Lydia; Stefanaki Kalliopi; Panayotopoulou Effie; Giannopoulou Ioanna; Athanassiadou Pauline; Gakiopoulou-Givalou Hariklia; Louvrou Androniki
Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation.
Human pathology 2002;33(9):863-70.
-
2002: Nakopoulou Lydia; Giannopoulou Ioanna; Stefanaki Kalliopi; Panayotopoulou Effie; Tsirmpa Ioanna; Alexandrou Paraskevi; Mavrommatis John; Katsarou Sophia; Davaris Panagiotis
Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis.
The Journal of pathology 2002;197(3):307-13.
-
2002: Nakopoulou L; Gakiopoulou-Givalou H; Karayiannakis A J; Giannopoulou I; Keramopoulos A; Davaris P; Pignatelli M
Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival.
Histopathology 2002;40(6):536-46.
-
2002: Nakopoulou Lydia; Tsirmpa Ioanna; Giannopoulou Ioanna; Trafalis Dimitrios; Katsarou Sophia; Davaris Panayiotis
Aneuploidy of chromosome 20 in invasive breast cancer correlates with poor outcome.
Cancer genetics and cytogenetics 2002;134(2):127-32.
-
2002: Nakopoulou Lydia; Giannopoulou Ioanna; Trafalis Dimitrios; Gakiopoulou Hariklia; Keramopoulos Antonios; Davaris Panayiotis
Evaluation of numeric alterations of chromosomes 1 and 17 by in situ hybridization in invasive breast carcinoma with clinicopathologic parameters.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2002;10(1):20-8.
-
2002: Nakopoulou Lydia; Lazaris Andreas Ch; Boletis Ioannis N; Michail Spyros; Giannopoulou Ioanna; Zeis Petros M; Stathakis Charalambos P; Davaris Panagiotis S
Evaluation of E-cadherin/catenin complex in primary and secondary glomerulonephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(3):469-74.
-
2002: Nakopoulou Lydia; Katsarou Sophia; Giannopoulou Ioanna; Alexandrou Paraskevi; Tsirmpa Ioanna; Panayotopoulou Effie; Mavrommatis Johnny; Keramopoulos Antonios
Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(1):26-34.
-
2001: Nakopoulou L; Gakiopoulou H; Zervas A; Giannopoulou I; Constantinides C; Lazaris A C; Liapis H; Kyriakou G; Dimopoulos C
MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: a comparison with clinicopathologic features and survival.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2001;9(2):130-7.
-
2000: Nakopoulou L; Gakiopoulou H; Keramopoulos A; Giannopoulou I; Athanassiadou P; Mavrommatis J; Davaris P S
c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma.
Histopathology 2000;36(4):313-25.
-
1999: Nakopoulou L; Lekkas N; Lazaris A C; Athanassiadou P; Giannopoulou I; Mavrommatis J; Davaris P
An immunohistochemical analysis of angiogenesis in invasive breast cancer with correlations to clinicopathologic predictors.
Anticancer research 1999;19(5C):4547-53.
-
1999: Nakopoulou L; Michalopoulou A; Giannopoulou I; Tzonou A; Keramopoulos A; Lazaris A C; Davaris P S
bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.
Histopathology 1999;34(4):310-9.
-
1999: Nakopoulou L; Giannopoulou I; Gakiopoulou H; Liapis H; Tzonou A; Davaris P S
Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features.
Human pathology 1999;30(4):436-42.
-
1995: Nakopoulou L; Janinis J; Giannopoulou I; Lazaris A C; Koureas A; Zacharoulis D
Immunohistochemical expression of p53 protein and proliferating cell nuclear antigen in hepatocellular carcinoma.
Pathology, research and practice 1995;191(12):1208-13.
-
1995: Nakopoulou L; Lazaris A C; Baltas D; Giannopoulou I; Kavantzas N; Tzonou A
Prognostic evaluation of oestrogen-regulated protein immunoreactivity in ductal invasive (NOS) breast cancer.
Virchows Archiv : an international journal of pathology 1995;427(1):33-40.
-
1994: Nakopoulou L; Stefanaki K; Filaktopoulos D; Giannopoulou I
C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.
Histology and histopathology 1994;9(4):677-82.
Sign-in to see more
